These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31585508)

  • 1. Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
    Wang L; Wang Y; Chen A; Teli M; Kondo R; Jalali A; Fan Y; Liu S; Zhao X; Siegel A; Minami K; Agarwal M; Li BY; Yokota H
    FASEB J; 2019 Dec; 33(12):13710-13721. PubMed ID: 31585508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemometric Analysis of Urinary Volatile Organic Compounds to Monitor the Efficacy of Pitavastatin Treatments on Mammary Tumor Progression over Time.
    Grocki P; Woollam M; Wang L; Liu S; Kalra M; Siegel AP; Li BY; Yokota H; Agarwal M
    Molecules; 2022 Jul; 27(13):. PubMed ID: 35807522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.
    Göbel A; Browne AJ; Thiele S; Rauner M; Hofbauer LC; Rachner TD
    Breast Cancer Res Treat; 2015 Dec; 154(3):623-31. PubMed ID: 26515701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells.
    Liu S; Fan Y; Chen A; Jalali A; Minami K; Ogawa K; Nakshatri H; Li BY; Yokota H
    Cancer Res; 2018 Jul; 78(14):3865-3876. PubMed ID: 29769195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo.
    Kojima Y; Ishida T; Sun L; Yasuda T; Toh R; Rikitake Y; Fukuda A; Kume N; Koshiyama H; Taniguchi A; Hirata K
    Cardiovasc Res; 2010 Jul; 87(2):385-93. PubMed ID: 20045866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin, a potent hydroxymethylglutaryl coenzyme a reductase inhibitor, increases cholesterol 7 alpha-hydroxylase gene expression in HepG2 cells.
    Fan P; Zhang B; Kuroki S; Saku K
    Circ J; 2004 Nov; 68(11):1061-6. PubMed ID: 15502389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
    Kanazawa I; Yamaguchi T; Yano S; Hayashi K; Yamauchi M; Sugimoto T
    Horm Metab Res; 2009 Aug; 41(8):612-6. PubMed ID: 19384817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.
    de Wolf E; Abdullah MI; Jones SM; Menezes K; Moss DM; Drijfhout FP; Hart SR; Hoskins C; Stronach EA; Richardson A
    Sci Rep; 2017 Jul; 7(1):5410. PubMed ID: 28710496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankle loading ameliorates bone loss from breast cancer-associated bone metastasis.
    Yang S; Liu H; Zhu L; Li X; Liu D; Song X; Yokota H; Zhang P
    FASEB J; 2019 Oct; 33(10):10742-10752. PubMed ID: 31266364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling.
    Hu T; Shen H; Huang H; Yang Z; Zhou Y; Zhao G
    Anticancer Drugs; 2020 Apr; 31(4):377-384. PubMed ID: 32011362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells.
    Jiang P; Mukthavaram R; Chao Y; Nomura N; Bharati IS; Fogal V; Pastorino S; Teng D; Cong X; Pingle SC; Kapoor S; Shetty K; Aggrawal A; Vali S; Abbasi T; Chien S; Kesari S
    Br J Cancer; 2014 Oct; 111(8):1562-71. PubMed ID: 25093497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet.
    Yoshida M; Nakamura K; Miyoshi T; Yoshida M; Kondo M; Akazawa K; Kimura T; Ohtsuka H; Ohno Y; Miura D; Ito H
    Cardiovasc Diabetol; 2020 Sep; 19(1):149. PubMed ID: 32979918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36.
    Han J; Zhou X; Yokoyama T; Hajjar DP; Gotto AM; Nicholson AC
    Circulation; 2004 Feb; 109(6):790-6. PubMed ID: 14970117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mevalonate Pathway-mediated ER Homeostasis Is Required for Haploid Stability in Human Somatic Cells.
    Yaguchi K; Sato K; Yoshizawa K; Mikami D; Yuyama K; Igarashi Y; Banhegyi G; Margittai E; Uehara R
    Cell Struct Funct; 2021 Feb; 46(1):1-9. PubMed ID: 33361684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin: clinical effects from the LIVES Study.
    Teramoto T
    Atheroscler Suppl; 2011 Nov; 12(3):285-8. PubMed ID: 22152283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.
    Rachner TD; Göbel A; Thiele S; Rauner M; Benad-Mehner P; Hadji P; Bauer T; Muders MH; Baretton GB; Jakob F; Ebert R; Bornhäuser M; Schem C; Hofbauer LC
    Breast Cancer Res; 2014 Feb; 16(1):R20. PubMed ID: 24528599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.